Answers are grounded in this paper and cite their sources.
Assesses PFAS immobilization in soil amendments, suggesting new strategies for contamination management.
; n = 8) was assessed using in vitro bioaccessibility (SBRC-I) and in vivo relative bioavailability (Sprague-Dawley rat bioassay) approaches. In unamended soil, PFOS bioaccessibility and relative bioavailability ranged from 29.5-86.5% (mean = 63.6%; median = 63.5%) and 44.8-107% (mean = 83.3%; median = 88.3%) respectively, reflective of the influence of soil physicochemical properties (total organic carbon and reactive Al and Fe content) on PFOS desorption under gastrointestinal conditions. However, following the addition of RemBind®300, PFOS bioaccessibility (range = 2.4-11.6%; mean = 5.6%; median = 5.4%) and PFOS relative bioavailability (range = 5.1-24.5%; mean = 13.0%; median = 14.8%) were significantly reduced (p < 0.05) due to RemBind®300 enhanced hydrophobic and electrostatic interactions which decreased PFOS desorption. When PFOS immobilization efficacy was calculated and compared to previously conducted leaching (99.1-100%) and earthworm (92.2-99.0%) assays, immobilization efficacy was significantly lower (p < 0.05) for bioaccessibility (80.0-95.4%) and relative bioavailability (69.0-95.0%) calculations attributable to factors such as assay complexity, presence/absence of enzymes/microbiota, pH, gut transit time and solid-to-solution ratio which influence PFOS desorption kinetics and thermodynamics.
No takes yet. Share an insight, caveat, or question.
Juhasz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: